SELLAS Life Sciences Group, Inc. (SLS)

NCM – Real Time Price. Currency in USD

11.66

+0.61 (5.52%)

Market open: Aug 12, 2026, 11:21 AM EDT

11.06

+0.01 (0.06%)

Previous after-hours: Aug 11, 2026, 7:59 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

Cost of goods sold

-557K

Gross Profit

443K

Operating expenses (excl. COGS)

-28M

-32M

-38M

-32M

Operating Income

-28M

-32M

-38M

-32M

Non-operating income, total

632K

529K

-9M

Pretax income

-27M

-31M

-37M

-41M

Equity in earnings

Taxes

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-27M

-31M

-37M

-41M

Discontinued operations

Net income

-27M

-31M

-37M

-41M

Dilution adjustment

Preferred dividends

SELLAS Life Sciences Group, Inc. (SLS)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

SELLAS Life Sciences Group, Inc. (SLS)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

SELLAS Life Sciences Group, Inc. (SLS)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

SELLAS Life Sciences Group, Inc. (SLS)

Income Statement (Annual)

Income Statement (Annual)